As determined by hematoxylin and eosin and Oil red O staining, along with detection of serum AST and ALT activity, 132 administration obviously ameliorated lipid accumulation in the liver and reduced the elevated serum ALT level in NAFLD rats, suggesting it as a potential agent for preventing NAFLD (Uemura et al., 2011; Cheng et al., 2018). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.